| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| JNK Mitogen-Activated Protein Kinases | 50 | 2021 | 127 | 8.010 |
Why?
|
| MAP Kinase Signaling System | 38 | 2023 | 203 | 7.730 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 36 | 2023 | 66 | 5.440 |
Why?
|
| Mitogen-Activated Protein Kinases | 35 | 2016 | 205 | 4.540 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 23 | 2021 | 39 | 3.490 |
Why?
|
| Signal Transduction | 50 | 2023 | 2902 | 3.380 |
Why?
|
| Adaptor Proteins, Signal Transducing | 13 | 2017 | 411 | 2.680 |
Why?
|
| Mice | 106 | 2021 | 10292 | 2.290 |
Why?
|
| Apoptosis | 31 | 2021 | 1032 | 2.250 |
Why?
|
| Insulin Resistance | 13 | 2020 | 392 | 2.060 |
Why?
|
| Adipose Tissue | 7 | 2020 | 283 | 2.030 |
Why?
|
| Animals | 119 | 2021 | 19651 | 1.940 |
Why?
|
| Obesity | 13 | 2020 | 1166 | 1.920 |
Why?
|
| Mice, Inbred C57BL | 42 | 2021 | 3231 | 1.700 |
Why?
|
| Stress, Physiological | 5 | 2017 | 185 | 1.670 |
Why?
|
| Fibroblast Growth Factors | 3 | 2020 | 66 | 1.640 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2023 | 193 | 1.580 |
Why?
|
| MAP Kinase Kinase Kinases | 7 | 2016 | 74 | 1.460 |
Why?
|
| Mice, Knockout | 42 | 2019 | 1994 | 1.440 |
Why?
|
| MAP Kinase Kinase 4 | 9 | 2020 | 38 | 1.390 |
Why?
|
| Phosphorylation | 35 | 2021 | 884 | 1.380 |
Why?
|
| Hepatocytes | 8 | 2020 | 196 | 1.360 |
Why?
|
| Enzyme Activation | 26 | 2018 | 359 | 1.240 |
Why?
|
| Tumor Necrosis Factor-alpha | 13 | 2011 | 588 | 1.230 |
Why?
|
| Gene Expression Regulation | 13 | 2020 | 1552 | 1.230 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 7 | 2010 | 98 | 1.210 |
Why?
|
| Diet, High-Fat | 9 | 2018 | 163 | 1.130 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 9 | 2005 | 53 | 1.080 |
Why?
|
| Liver | 7 | 2020 | 797 | 1.080 |
Why?
|
| Mammary Glands, Animal | 3 | 2018 | 78 | 1.010 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2010 | 318 | 1.000 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 14 | 2016 | 127 | 0.990 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 8 | 2019 | 12 | 0.990 |
Why?
|
| Autocrine Communication | 3 | 2020 | 32 | 0.990 |
Why?
|
| Epithelial Cells | 7 | 2021 | 391 | 0.960 |
Why?
|
| Interleukin-6 | 9 | 2020 | 310 | 0.960 |
Why?
|
| Cell Survival | 7 | 2018 | 559 | 0.950 |
Why?
|
| Neurons | 9 | 2019 | 863 | 0.890 |
Why?
|
| Apoptosis Regulatory Proteins | 5 | 2017 | 146 | 0.870 |
Why?
|
| Cells, Cultured | 25 | 2018 | 2093 | 0.850 |
Why?
|
| Myeloid Cells | 3 | 2020 | 89 | 0.840 |
Why?
|
| Liver Neoplasms | 3 | 2017 | 277 | 0.830 |
Why?
|
| Autophagy | 2 | 2018 | 213 | 0.820 |
Why?
|
| Hepatitis | 2 | 2016 | 55 | 0.810 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2017 | 168 | 0.800 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 1118 | 0.720 |
Why?
|
| Proto-Oncogene Proteins c-jun | 6 | 2007 | 26 | 0.710 |
Why?
|
| Carcinogenesis | 3 | 2018 | 118 | 0.700 |
Why?
|
| Adipocytes | 6 | 2020 | 255 | 0.700 |
Why?
|
| Fibroblasts | 12 | 2011 | 377 | 0.690 |
Why?
|
| Membrane Proteins | 7 | 2012 | 850 | 0.680 |
Why?
|
| Publishing | 2 | 2018 | 90 | 0.650 |
Why?
|
| Ischemia | 3 | 2019 | 199 | 0.650 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2011 | 289 | 0.650 |
Why?
|
| Transcription Factor AP-1 | 6 | 2018 | 41 | 0.650 |
Why?
|
| Prostatic Neoplasms | 5 | 2015 | 339 | 0.630 |
Why?
|
| Genomic Instability | 2 | 2018 | 53 | 0.610 |
Why?
|
| Inflammation | 5 | 2021 | 1099 | 0.610 |
Why?
|
| Macrophages | 5 | 2020 | 1015 | 0.590 |
Why?
|
| Anoikis | 1 | 2017 | 4 | 0.580 |
Why?
|
| Insulin | 8 | 2016 | 674 | 0.580 |
Why?
|
| Amino Acids | 1 | 2018 | 140 | 0.560 |
Why?
|
| Mitochondrial Proteins | 2 | 2016 | 100 | 0.560 |
Why?
|
| src-Family Kinases | 1 | 2017 | 60 | 0.560 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2016 | 327 | 0.560 |
Why?
|
| ras Proteins | 3 | 2018 | 77 | 0.560 |
Why?
|
| Journal Impact Factor | 1 | 2017 | 17 | 0.560 |
Why?
|
| Cell Proliferation | 11 | 2021 | 942 | 0.550 |
Why?
|
| Models, Biological | 8 | 2016 | 1143 | 0.540 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2017 | 59 | 0.530 |
Why?
|
| RNA-Binding Proteins | 3 | 2016 | 386 | 0.530 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2015 | 83 | 0.520 |
Why?
|
| Transcription Factors | 9 | 2016 | 1471 | 0.520 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2015 | 188 | 0.520 |
Why?
|
| Mice, Transgenic | 12 | 2014 | 1206 | 0.510 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 258 | 0.510 |
Why?
|
| Molecular Mimicry | 1 | 2016 | 31 | 0.510 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2016 | 71 | 0.510 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 133 | 0.500 |
Why?
|
| Leukemia | 1 | 2016 | 57 | 0.500 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 101 | 0.500 |
Why?
|
| Research | 1 | 2017 | 188 | 0.500 |
Why?
|
| Alternative Splicing | 1 | 2016 | 122 | 0.500 |
Why?
|
| Femoral Artery | 1 | 2016 | 101 | 0.490 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 54 | 0.490 |
Why?
|
| Nerve Tissue Proteins | 4 | 2008 | 418 | 0.490 |
Why?
|
| Thermogenesis | 1 | 2016 | 116 | 0.480 |
Why?
|
| Cell Differentiation | 8 | 2010 | 1304 | 0.480 |
Why?
|
| Fatty Liver | 3 | 2011 | 98 | 0.470 |
Why?
|
| Insulin Receptor Substrate Proteins | 4 | 2009 | 55 | 0.470 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 55 | 0.460 |
Why?
|
| Male | 37 | 2021 | 27739 | 0.460 |
Why?
|
| Carrier Proteins | 5 | 2007 | 697 | 0.460 |
Why?
|
| PPAR alpha | 1 | 2014 | 29 | 0.450 |
Why?
|
| Neoplasms | 6 | 2016 | 1240 | 0.440 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 23 | 0.440 |
Why?
|
| DNA-Binding Proteins | 6 | 2016 | 1151 | 0.420 |
Why?
|
| Melanoma | 1 | 2017 | 329 | 0.420 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2007 | 119 | 0.400 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2015 | 75 | 0.390 |
Why?
|
| Adenocarcinoma | 2 | 2012 | 323 | 0.390 |
Why?
|
| Humans | 41 | 2023 | 59360 | 0.370 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2011 | 62 | 0.370 |
Why?
|
| Bcl-2-Like Protein 11 | 4 | 2019 | 19 | 0.370 |
Why?
|
| Cell Line | 14 | 2018 | 1984 | 0.370 |
Why?
|
| Cellular Senescence | 3 | 2017 | 104 | 0.360 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2019 | 46 | 0.360 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 125 | 0.360 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 631 | 0.350 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 70 | 0.350 |
Why?
|
| Cell Line, Tumor | 9 | 2023 | 1370 | 0.340 |
Why?
|
| Protein Kinases | 3 | 2010 | 142 | 0.340 |
Why?
|
| Reactive Oxygen Species | 3 | 2007 | 205 | 0.340 |
Why?
|
| Female | 19 | 2023 | 30705 | 0.340 |
Why?
|
| Pituitary Gland | 1 | 2010 | 51 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 475 | 0.330 |
Why?
|
| Dietary Fats | 5 | 2011 | 173 | 0.330 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 2050 | 0.320 |
Why?
|
| Thyroid Gland | 1 | 2010 | 79 | 0.320 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 88 | 0.320 |
Why?
|
| Cytokines | 5 | 2012 | 912 | 0.320 |
Why?
|
| DNA Fragmentation | 2 | 2006 | 35 | 0.320 |
Why?
|
| Caspase 8 | 2 | 2021 | 61 | 0.310 |
Why?
|
| MAP Kinase Kinase 7 | 5 | 2014 | 9 | 0.310 |
Why?
|
| Cell Movement | 5 | 2016 | 429 | 0.310 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 88 | 0.310 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 151 | 0.310 |
Why?
|
| Energy Metabolism | 3 | 2020 | 359 | 0.310 |
Why?
|
| Transcription, Genetic | 10 | 2016 | 844 | 0.310 |
Why?
|
| Cell Lineage | 1 | 2010 | 259 | 0.310 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2012 | 540 | 0.300 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2012 | 425 | 0.300 |
Why?
|
| Protein Isoforms | 6 | 2008 | 192 | 0.290 |
Why?
|
| Trans-Activators | 3 | 2004 | 300 | 0.290 |
Why?
|
| N-Methylaspartate | 1 | 2007 | 14 | 0.290 |
Why?
|
| Gene Deletion | 4 | 2020 | 293 | 0.280 |
Why?
|
| Motor Neurons | 3 | 2006 | 203 | 0.280 |
Why?
|
| Feedback, Physiological | 2 | 2020 | 59 | 0.280 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2007 | 56 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2007 | 8 | 0.280 |
Why?
|
| Mice, Nude | 5 | 2013 | 258 | 0.280 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 582 | 0.280 |
Why?
|
| Mutation | 6 | 2021 | 2456 | 0.270 |
Why?
|
| Gene Expression Regulation, Developmental | 6 | 2015 | 619 | 0.270 |
Why?
|
| Muscle, Skeletal | 2 | 2019 | 674 | 0.260 |
Why?
|
| Oncogenes | 1 | 2006 | 66 | 0.260 |
Why?
|
| Cell Death | 7 | 2021 | 271 | 0.250 |
Why?
|
| Oxidative Stress | 2 | 2007 | 279 | 0.250 |
Why?
|
| Ultraviolet Rays | 4 | 2009 | 127 | 0.250 |
Why?
|
| Liver Regeneration | 3 | 2017 | 18 | 0.240 |
Why?
|
| Nuclear Proteins | 3 | 2005 | 750 | 0.240 |
Why?
|
| Coiled Bodies | 1 | 2005 | 4 | 0.240 |
Why?
|
| MAP Kinase Kinase 3 | 6 | 2014 | 10 | 0.240 |
Why?
|
| Histones | 2 | 2017 | 458 | 0.240 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 48 | 0.230 |
Why?
|
| Base Sequence | 9 | 2016 | 1302 | 0.230 |
Why?
|
| T-Lymphocytes | 3 | 2010 | 986 | 0.230 |
Why?
|
| Morphogenesis | 3 | 2016 | 108 | 0.230 |
Why?
|
| Reperfusion Injury | 2 | 2021 | 49 | 0.220 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2005 | 190 | 0.220 |
Why?
|
| Telencephalon | 1 | 2003 | 10 | 0.220 |
Why?
|
| Coloboma | 1 | 2003 | 1 | 0.210 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 170 | 0.210 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 2 | 2021 | 79 | 0.210 |
Why?
|
| Muscle Cells | 2 | 2020 | 26 | 0.210 |
Why?
|
| Immunologic Memory | 2 | 2019 | 281 | 0.200 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 57 | 0.200 |
Why?
|
| Gene Expression | 4 | 2011 | 809 | 0.200 |
Why?
|
| Vesicular Transport Proteins | 1 | 2003 | 106 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2016 | 172 | 0.200 |
Why?
|
| Islets of Langerhans | 2 | 2015 | 271 | 0.200 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2019 | 648 | 0.190 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2021 | 6 | 0.190 |
Why?
|
| Phosphoproteins | 4 | 2014 | 211 | 0.190 |
Why?
|
| Mitochondria | 5 | 2007 | 343 | 0.190 |
Why?
|
| Lung | 3 | 2020 | 919 | 0.190 |
Why?
|
| Glucose | 5 | 2018 | 445 | 0.190 |
Why?
|
| Mice, Mutant Strains | 4 | 2010 | 297 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 194 | 0.190 |
Why?
|
| TRPP Cation Channels | 1 | 2021 | 25 | 0.190 |
Why?
|
| Chromatin | 1 | 2006 | 599 | 0.190 |
Why?
|
| Skin | 1 | 2004 | 357 | 0.190 |
Why?
|
| Axons | 3 | 2015 | 118 | 0.190 |
Why?
|
| Immunohistochemistry | 6 | 2021 | 847 | 0.180 |
Why?
|
| Bile Duct Diseases | 1 | 2021 | 9 | 0.180 |
Why?
|
| Recombinant Proteins | 5 | 2009 | 689 | 0.180 |
Why?
|
| Blood Glucose | 2 | 2016 | 461 | 0.180 |
Why?
|
| Cysts | 1 | 2021 | 40 | 0.180 |
Why?
|
| Endocrine System | 1 | 2020 | 17 | 0.180 |
Why?
|
| Adiponectin | 1 | 2020 | 34 | 0.180 |
Why?
|
| Phenotype | 3 | 2018 | 1137 | 0.170 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2020 | 53 | 0.170 |
Why?
|
| ADAM17 Protein | 1 | 2020 | 9 | 0.170 |
Why?
|
| ADAM10 Protein | 1 | 2020 | 11 | 0.170 |
Why?
|
| Editorial Policies | 2 | 2018 | 52 | 0.170 |
Why?
|
| DNA Damage | 2 | 2017 | 279 | 0.170 |
Why?
|
| Phosphotransferases | 1 | 1999 | 21 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2009 | 248 | 0.170 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2019 | 15 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 4 | 2010 | 657 | 0.160 |
Why?
|
| Hindlimb | 1 | 2019 | 44 | 0.160 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 550 | 0.160 |
Why?
|
| Organ Specificity | 2 | 2010 | 183 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2011 | 52 | 0.160 |
Why?
|
| Embryo, Mammalian | 3 | 2010 | 156 | 0.160 |
Why?
|
| Species Specificity | 1 | 2020 | 329 | 0.160 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 132 | 0.160 |
Why?
|
| Amino Acid Sequence | 6 | 2010 | 1554 | 0.160 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2009 | 40 | 0.160 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 1952 | 0.150 |
Why?
|
| Bone Marrow | 2 | 2014 | 177 | 0.150 |
Why?
|
| Mesoderm | 2 | 2010 | 81 | 0.150 |
Why?
|
| Naphthyridines | 1 | 2018 | 6 | 0.150 |
Why?
|
| Hyperglycemia | 2 | 2016 | 98 | 0.150 |
Why?
|
| fas Receptor | 1 | 2019 | 55 | 0.150 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 42 | 0.150 |
Why?
|
| Cell Biology | 1 | 2018 | 21 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 191 | 0.150 |
Why?
|
| Smad2 Protein | 1 | 2018 | 8 | 0.150 |
Why?
|
| Matrix Metalloproteinases | 1 | 2018 | 16 | 0.150 |
Why?
|
| Exome | 1 | 2018 | 73 | 0.150 |
Why?
|
| Cathepsins | 1 | 2018 | 34 | 0.150 |
Why?
|
| Immunophenotyping | 2 | 2021 | 184 | 0.140 |
Why?
|
| DNA Mutational Analysis | 3 | 2009 | 188 | 0.140 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2018 | 117 | 0.140 |
Why?
|
| Molecular Biology | 1 | 2018 | 66 | 0.140 |
Why?
|
| Phosphotyrosine | 1 | 2017 | 23 | 0.140 |
Why?
|
| Palmitates | 1 | 2017 | 21 | 0.140 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2020 | 155 | 0.140 |
Why?
|
| Heat-Shock Proteins | 1 | 2018 | 65 | 0.140 |
Why?
|
| Lactation | 1 | 2018 | 66 | 0.140 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 67 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 2 | 2012 | 392 | 0.140 |
Why?
|
| Point Mutation | 2 | 2009 | 160 | 0.140 |
Why?
|
| RNA, Messenger | 6 | 2014 | 1465 | 0.140 |
Why?
|
| NF-kappa B | 3 | 2005 | 460 | 0.140 |
Why?
|
| beta Catenin | 2 | 2008 | 86 | 0.140 |
Why?
|
| Membrane Microdomains | 1 | 2017 | 49 | 0.140 |
Why?
|
| Protein Domains | 1 | 2017 | 140 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 196 | 0.130 |
Why?
|
| Immunoblotting | 2 | 2010 | 188 | 0.130 |
Why?
|
| Lymphocytic Choriomeningitis | 2 | 2010 | 53 | 0.130 |
Why?
|
| Protein Binding | 5 | 2016 | 1557 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 3 | 2019 | 868 | 0.130 |
Why?
|
| Peroxisomal Bifunctional Enzyme | 1 | 2016 | 1 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 178 | 0.130 |
Why?
|
| Time Factors | 6 | 2007 | 3617 | 0.130 |
Why?
|
| Agouti-Related Protein | 1 | 2016 | 6 | 0.130 |
Why?
|
| Resistin | 1 | 2016 | 6 | 0.130 |
Why?
|
| Hyperphagia | 1 | 2016 | 18 | 0.130 |
Why?
|
| Isoenzymes | 4 | 2014 | 136 | 0.130 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2013 | 30 | 0.130 |
Why?
|
| Radiation Tolerance | 2 | 2013 | 49 | 0.120 |
Why?
|
| Leptin | 1 | 2016 | 83 | 0.120 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2015 | 8 | 0.120 |
Why?
|
| Macrophage Activation | 2 | 2012 | 118 | 0.120 |
Why?
|
| Aging | 1 | 2021 | 710 | 0.120 |
Why?
|
| Muscle Proteins | 1 | 2016 | 111 | 0.120 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 26 | 0.120 |
Why?
|
| Panniculitis | 1 | 2015 | 4 | 0.120 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 23 | 0.120 |
Why?
|
| In Vitro Techniques | 4 | 2003 | 471 | 0.120 |
Why?
|
| Acetyl Coenzyme A | 1 | 2015 | 22 | 0.120 |
Why?
|
| Presynaptic Terminals | 1 | 2015 | 37 | 0.120 |
Why?
|
| Fetus | 1 | 2015 | 93 | 0.120 |
Why?
|
| Intestines | 2 | 2007 | 158 | 0.120 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 2 | 2017 | 19 | 0.120 |
Why?
|
| Interferon-gamma | 3 | 2007 | 551 | 0.120 |
Why?
|
| Homeostasis | 3 | 2019 | 346 | 0.120 |
Why?
|
| Periodicals as Topic | 1 | 2017 | 166 | 0.120 |
Why?
|
| 3T3 Cells | 3 | 2012 | 108 | 0.120 |
Why?
|
| Cell Division | 2 | 2007 | 443 | 0.120 |
Why?
|
| Glutamic Acid | 1 | 2015 | 95 | 0.120 |
Why?
|
| bcl-2-Associated X Protein | 3 | 2003 | 42 | 0.110 |
Why?
|
| Computational Biology | 1 | 2016 | 333 | 0.110 |
Why?
|
| Steroids | 1 | 2014 | 53 | 0.110 |
Why?
|
| Cell Cycle | 3 | 2006 | 382 | 0.110 |
Why?
|
| Gene Targeting | 2 | 2005 | 78 | 0.110 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2013 | 30 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 178 | 0.110 |
Why?
|
| Genes, Reporter | 3 | 2003 | 241 | 0.110 |
Why?
|
| Interleukin-10 | 2 | 2006 | 149 | 0.110 |
Why?
|
| Integrin beta1 | 1 | 2013 | 28 | 0.110 |
Why?
|
| MAP Kinase Kinase 6 | 3 | 2014 | 4 | 0.110 |
Why?
|
| Thyroid Hormones | 1 | 2013 | 74 | 0.100 |
Why?
|
| Kinetics | 2 | 2007 | 751 | 0.100 |
Why?
|
| Pancreas | 2 | 2014 | 147 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2014 | 106 | 0.100 |
Why?
|
| Carbon Monoxide | 2 | 2003 | 61 | 0.100 |
Why?
|
| Glucose Clamp Technique | 1 | 2012 | 57 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 2011 | 450 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 96 | 0.100 |
Why?
|
| Ganglia, Spinal | 2 | 2010 | 24 | 0.100 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2012 | 31 | 0.100 |
Why?
|
| Histological Techniques | 1 | 2012 | 18 | 0.100 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2012 | 3 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2010 | 111 | 0.100 |
Why?
|
| Neuropilin-2 | 1 | 2012 | 39 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 36 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2011 | 3 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2011 | 12 | 0.100 |
Why?
|
| Plaque, Amyloid | 1 | 2011 | 38 | 0.100 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2011 | 21 | 0.090 |
Why?
|
| Serine | 2 | 2010 | 83 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 651 | 0.090 |
Why?
|
| RNA | 1 | 2015 | 401 | 0.090 |
Why?
|
| Rats | 5 | 2021 | 1910 | 0.090 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2011 | 77 | 0.090 |
Why?
|
| Caspases | 2 | 2002 | 166 | 0.090 |
Why?
|
| Tyrosine | 1 | 2011 | 92 | 0.090 |
Why?
|
| Binding Sites | 5 | 2007 | 881 | 0.090 |
Why?
|
| Contact Inhibition | 1 | 2011 | 3 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 527 | 0.090 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2011 | 16 | 0.090 |
Why?
|
| Wnt Proteins | 2 | 2008 | 92 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 25 | 0.090 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2011 | 17 | 0.090 |
Why?
|
| Beclin-1 | 1 | 2011 | 20 | 0.090 |
Why?
|
| Microtubules | 2 | 2010 | 211 | 0.090 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2010 | 5 | 0.090 |
Why?
|
| Intestinal Neoplasms | 2 | 2008 | 13 | 0.090 |
Why?
|
| Hippocampus | 2 | 2010 | 246 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 40 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 331 | 0.090 |
Why?
|
| Association Learning | 1 | 2010 | 8 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 44 | 0.090 |
Why?
|
| DNA Primers | 2 | 2009 | 289 | 0.090 |
Why?
|
| Cadherins | 1 | 2011 | 69 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 197 | 0.090 |
Why?
|
| Neurites | 1 | 2010 | 22 | 0.090 |
Why?
|
| Amino Acid Substitution | 2 | 2009 | 234 | 0.090 |
Why?
|
| Adipokines | 1 | 2010 | 28 | 0.090 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2010 | 5 | 0.090 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2019 | 88 | 0.090 |
Why?
|
| Caspase 3 | 3 | 2013 | 103 | 0.090 |
Why?
|
| Nerve Regeneration | 1 | 2010 | 31 | 0.090 |
Why?
|
| Hydrocolpos | 1 | 2010 | 1 | 0.080 |
Why?
|
| Limb Deformities, Congenital | 1 | 2010 | 3 | 0.080 |
Why?
|
| Cyclic AMP | 1 | 2010 | 142 | 0.080 |
Why?
|
| Poly I-C | 1 | 2010 | 76 | 0.080 |
Why?
|
| Teratoma | 1 | 2010 | 11 | 0.080 |
Why?
|
| Enzyme Inhibitors | 4 | 2006 | 349 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2016 | 250 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 495 | 0.080 |
Why?
|
| Organogenesis | 1 | 2010 | 38 | 0.080 |
Why?
|
| Dendrites | 1 | 2010 | 56 | 0.080 |
Why?
|
| COS Cells | 2 | 2007 | 173 | 0.080 |
Why?
|
| Vagina | 1 | 2010 | 79 | 0.080 |
Why?
|
| Cell Separation | 1 | 2010 | 145 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2010 | 306 | 0.080 |
Why?
|
| Drosophila | 2 | 2003 | 421 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2008 | 8 | 0.080 |
Why?
|
| Eating | 1 | 2010 | 130 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2010 | 555 | 0.080 |
Why?
|
| Kidney | 2 | 2021 | 416 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 14 | 0.080 |
Why?
|
| rho-Associated Kinases | 1 | 2008 | 11 | 0.080 |
Why?
|
| Lymphocytes | 1 | 2010 | 190 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2008 | 105 | 0.080 |
Why?
|
| Interleukin-2 | 3 | 2004 | 164 | 0.080 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 170 | 0.080 |
Why?
|
| Conserved Sequence | 3 | 2007 | 170 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2008 | 64 | 0.080 |
Why?
|
| Proteome | 1 | 2009 | 141 | 0.070 |
Why?
|
| Radiation Injuries | 1 | 2008 | 62 | 0.070 |
Why?
|
| Epithelium | 1 | 2008 | 96 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 426 | 0.070 |
Why?
|
| Ehrlichiosis | 1 | 2007 | 6 | 0.070 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2007 | 9 | 0.070 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2007 | 22 | 0.070 |
Why?
|
| Cerebral Cortex | 2 | 2015 | 248 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2007 | 52 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2008 | 229 | 0.070 |
Why?
|
| Hypoxia | 2 | 2005 | 112 | 0.070 |
Why?
|
| Protein Transport | 2 | 2006 | 399 | 0.070 |
Why?
|
| Protein Kinase C | 1 | 2007 | 98 | 0.070 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2006 | 11 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 718 | 0.070 |
Why?
|
| Liver Failure, Acute | 1 | 2006 | 16 | 0.070 |
Why?
|
| Cerebellum | 1 | 2007 | 91 | 0.070 |
Why?
|
| Axis, Cervical Vertebra | 1 | 2006 | 4 | 0.070 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2007 | 620 | 0.070 |
Why?
|
| Myocardium | 2 | 2006 | 264 | 0.070 |
Why?
|
| Activating Transcription Factor 2 | 2 | 2004 | 12 | 0.070 |
Why?
|
| Oncogene Proteins | 1 | 2006 | 31 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2010 | 515 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 574 | 0.070 |
Why?
|
| Xenopus | 1 | 2006 | 54 | 0.070 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2006 | 35 | 0.070 |
Why?
|
| Borrelia burgdorferi | 1 | 2007 | 68 | 0.070 |
Why?
|
| RNA Interference | 2 | 2012 | 590 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 43 | 0.070 |
Why?
|
| Acetaminophen | 1 | 2006 | 49 | 0.070 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2006 | 57 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2010 | 442 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 2003 | 164 | 0.060 |
Why?
|
| Cardiomegaly | 1 | 2006 | 29 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2006 | 169 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2006 | 65 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2010 | 43 | 0.060 |
Why?
|
| Interleukin-1 | 2 | 2003 | 157 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 70 | 0.060 |
Why?
|
| Pyrimidines | 1 | 2006 | 131 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2006 | 333 | 0.060 |
Why?
|
| Ribonucleoproteins, Small Nucleolar | 1 | 2005 | 3 | 0.060 |
Why?
|
| SMN Complex Proteins | 1 | 2005 | 5 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2006 | 608 | 0.060 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2005 | 7 | 0.060 |
Why?
|
| Lipopolysaccharides | 3 | 2003 | 627 | 0.060 |
Why?
|
| Th2 Cells | 1 | 2005 | 99 | 0.060 |
Why?
|
| Eyelids | 1 | 2004 | 7 | 0.060 |
Why?
|
| Cricetinae | 2 | 2002 | 366 | 0.060 |
Why?
|
| Spliceosomes | 1 | 2005 | 41 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2004 | 43 | 0.060 |
Why?
|
| Tongue | 1 | 2004 | 15 | 0.060 |
Why?
|
| Receptor Cross-Talk | 1 | 2004 | 10 | 0.060 |
Why?
|
| Activin Receptors, Type I | 1 | 2004 | 14 | 0.060 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 29 | 0.060 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 40 | 0.060 |
Why?
|
| Genes, Dominant | 1 | 2004 | 55 | 0.060 |
Why?
|
| Th1 Cells | 1 | 2005 | 174 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 381 | 0.060 |
Why?
|
| Homozygote | 1 | 2004 | 114 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 214 | 0.060 |
Why?
|
| Biopsy | 2 | 2021 | 411 | 0.060 |
Why?
|
| Immune System | 1 | 2005 | 129 | 0.060 |
Why?
|
| Longevity | 1 | 2005 | 110 | 0.060 |
Why?
|
| High Mobility Group Proteins | 1 | 2003 | 20 | 0.060 |
Why?
|
| Mice, SCID | 1 | 2005 | 513 | 0.060 |
Why?
|
| Immunoassay | 1 | 2004 | 67 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2007 | 763 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2005 | 270 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2005 | 516 | 0.050 |
Why?
|
| Munc18 Proteins | 1 | 2003 | 12 | 0.050 |
Why?
|
| PAX2 Transcription Factor | 1 | 2003 | 1 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2003 | 8 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 27 | 0.050 |
Why?
|
| Lens, Crystalline | 1 | 2003 | 15 | 0.050 |
Why?
|
| GTPase-Activating Proteins | 1 | 2003 | 64 | 0.050 |
Why?
|
| Threonine | 1 | 2003 | 15 | 0.050 |
Why?
|
| Hyperoxia | 1 | 2003 | 16 | 0.050 |
Why?
|
| Wound Healing | 1 | 2004 | 174 | 0.050 |
Why?
|
| Crosses, Genetic | 2 | 2017 | 105 | 0.050 |
Why?
|
| Blotting, Western | 3 | 2010 | 584 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2003 | 61 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2003 | 75 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2007 | 1128 | 0.050 |
Why?
|
| MEF2 Transcription Factors | 1 | 2002 | 10 | 0.050 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2002 | 11 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 111 | 0.050 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 24 | 0.050 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2002 | 12 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2005 | 378 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2017 | 23 | 0.050 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 223 | 0.050 |
Why?
|
| Hedgehog Proteins | 1 | 2003 | 109 | 0.050 |
Why?
|
| Plasmids | 1 | 2003 | 279 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2002 | 43 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 281 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 68 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 515 | 0.050 |
Why?
|
| Inflammation Mediators | 1 | 2003 | 170 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 150 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2002 | 51 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2002 | 100 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2002 | 73 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 178 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2002 | 253 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2003 | 332 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2002 | 193 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2003 | 170 | 0.050 |
Why?
|
| Viruses | 1 | 2002 | 78 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2002 | 424 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2021 | 18 | 0.050 |
Why?
|
| Proteins | 2 | 2003 | 730 | 0.040 |
Why?
|
| Diet | 1 | 2004 | 497 | 0.040 |
Why?
|
| Brain | 2 | 2006 | 1488 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 157 | 0.040 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2005 | 397 | 0.040 |
Why?
|
| Bleomycin | 1 | 2020 | 32 | 0.040 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2021 | 138 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 743 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2019 | 108 | 0.040 |
Why?
|
| Transfection | 3 | 2008 | 675 | 0.040 |
Why?
|
| Arenaviridae Infections | 1 | 2019 | 15 | 0.040 |
Why?
|
| Scientific Experimental Error | 1 | 2018 | 1 | 0.040 |
Why?
|
| Retraction of Publication as Topic | 1 | 2018 | 1 | 0.040 |
Why?
|
| Scientific Misconduct | 1 | 2018 | 12 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2005 | 623 | 0.040 |
Why?
|
| Skin Transplantation | 1 | 2019 | 155 | 0.040 |
Why?
|
| Anisomycin | 2 | 2010 | 6 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 9 | 0.040 |
Why?
|
| Interleukin-13 | 1 | 2018 | 37 | 0.040 |
Why?
|
| Fas-Associated Death Domain Protein | 1 | 2017 | 11 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2017 | 60 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 55 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 857 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2008 | 133 | 0.030 |
Why?
|
| Intestinal Mucosa | 2 | 2008 | 225 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 242 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 96 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2015 | 18 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 34 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 914 | 0.030 |
Why?
|
| Synaptosomes | 1 | 2015 | 16 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 245 | 0.030 |
Why?
|
| Anthracenes | 2 | 2006 | 12 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2015 | 27 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 2015 | 42 | 0.030 |
Why?
|
| Exocytosis | 1 | 2015 | 59 | 0.030 |
Why?
|
| Biomarkers | 2 | 2015 | 1306 | 0.030 |
Why?
|
| Armadillo Domain Proteins | 1 | 2015 | 22 | 0.030 |
Why?
|
| Lipolysis | 1 | 2015 | 47 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 294 | 0.030 |
Why?
|
| Bucladesine | 1 | 2014 | 6 | 0.030 |
Why?
|
| Oxidants | 1 | 2014 | 18 | 0.030 |
Why?
|
| Adipose Tissue, White | 1 | 2015 | 86 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2014 | 4 | 0.030 |
Why?
|
| Acinar Cells | 1 | 2014 | 8 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 5824 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2017 | 716 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 159 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 224 | 0.030 |
Why?
|
| Risk Factors | 2 | 2017 | 4984 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 196 | 0.030 |
Why?
|
| Regeneration | 1 | 2014 | 93 | 0.030 |
Why?
|
| Dependovirus | 1 | 2020 | 652 | 0.030 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2003 | 8 | 0.030 |
Why?
|
| Progesterone | 1 | 2014 | 158 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2014 | 172 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2015 | 289 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 134 | 0.030 |
Why?
|
| Vitamin A | 1 | 2012 | 26 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2012 | 95 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 587 | 0.020 |
Why?
|
| Oxygen | 2 | 2003 | 313 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 188 | 0.020 |
Why?
|
| Cell Communication | 1 | 2012 | 124 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 230 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 88 | 0.020 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2010 | 4 | 0.020 |
Why?
|
| Amnesia | 1 | 2010 | 9 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 62 | 0.020 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 9 | 0.020 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2010 | 34 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 106 | 0.020 |
Why?
|
| Spleen | 2 | 2002 | 480 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 23 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2010 | 90 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 339 | 0.020 |
Why?
|
| Cell Surface Extensions | 1 | 2010 | 6 | 0.020 |
Why?
|
| Disease Progression | 2 | 2006 | 1122 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2010 | 15 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 288 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1782 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2008 | 63 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 217 | 0.020 |
Why?
|
| Genotype | 1 | 2010 | 617 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 635 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2008 | 66 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2202 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 25 | 0.020 |
Why?
|
| Antigens, CD1d | 1 | 2007 | 28 | 0.020 |
Why?
|
| Antigens, CD1 | 1 | 2007 | 42 | 0.020 |
Why?
|
| Guanosine Diphosphate | 1 | 2007 | 19 | 0.020 |
Why?
|
| Carbon Tetrachloride | 1 | 2006 | 9 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2007 | 59 | 0.020 |
Why?
|
| Dishevelled Proteins | 1 | 2006 | 6 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 452 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 12 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2006 | 9 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 13 | 0.020 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2006 | 13 | 0.020 |
Why?
|
| Myelin Proteins | 1 | 2006 | 30 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 51 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2007 | 218 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 147 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 283 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 61 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2006 | 112 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2006 | 96 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2005 | 9 | 0.020 |
Why?
|
| Glutathione Peroxidase | 1 | 2005 | 27 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 215 | 0.020 |
Why?
|
| DNA, Helminth | 1 | 2005 | 9 | 0.020 |
Why?
|
| Aorta | 1 | 2006 | 108 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4267 | 0.020 |
Why?
|
| Thiazoles | 1 | 2005 | 46 | 0.020 |
Why?
|
| Methacrylates | 1 | 2005 | 37 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 32 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 298 | 0.010 |
Why?
|
| Genes, Helminth | 1 | 2005 | 53 | 0.010 |
Why?
|
| Phosphoserine | 1 | 2004 | 10 | 0.010 |
Why?
|
| Axotomy | 1 | 2004 | 8 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 2004 | 24 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2006 | 223 | 0.010 |
Why?
|
| Face | 1 | 2004 | 33 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 108 | 0.010 |
Why?
|
| Phosphopeptides | 1 | 2004 | 9 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 65 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 297 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 280 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 384 | 0.010 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2003 | 3 | 0.010 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2003 | 11 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2003 | 26 | 0.010 |
Why?
|
| G1 Phase | 1 | 2003 | 55 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 62 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2006 | 495 | 0.010 |
Why?
|
| Heme Oxygenase-1 | 1 | 2003 | 18 | 0.010 |
Why?
|
| Mothers | 1 | 2006 | 255 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2003 | 44 | 0.010 |
Why?
|
| Imidazoles | 1 | 2003 | 77 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2002 | 26 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 2002 | 8 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2002 | 29 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2002 | 48 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2002 | 39 | 0.010 |
Why?
|
| Pyridines | 1 | 2003 | 98 | 0.010 |
Why?
|
| Peroxidase | 1 | 2003 | 70 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2002 | 50 | 0.010 |
Why?
|
| Myoblasts | 1 | 2003 | 63 | 0.010 |
Why?
|
| NFATC Transcription Factors | 1 | 2002 | 20 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2004 | 400 | 0.010 |
Why?
|
| Camptothecin | 1 | 2002 | 22 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2003 | 343 | 0.010 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2002 | 25 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2002 | 39 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2002 | 165 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2002 | 146 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2002 | 356 | 0.010 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2002 | 69 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2002 | 109 | 0.010 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 142 | 0.010 |
Why?
|
| Immunity | 1 | 2002 | 101 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 214 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 490 | 0.010 |
Why?
|
| Influenza A virus | 1 | 2002 | 116 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2006 | 774 | 0.010 |
Why?
|
| Neutrophils | 1 | 2003 | 363 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 806 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 15669 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 16317 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 676 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2008 | 5284 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2003 | 862 | 0.010 |
Why?
|